Unknown

Dataset Information

0

Engineering the oleaginous yeast Yarrowia lipolytica for high-level resveratrol production.


ABSTRACT: Resveratrol is a plant secondary metabolite with multiple health-beneficial properties. Microbial production of resveratrol in model microorganisms requires extensive engineering to reach commercially viable levels. Here, we explored the potential of the non-conventional yeast Yarrowia lipolytica to produce resveratrol and several other shikimate pathway-derived metabolites (p-coumaric acid, cis,cis-muconic acid, and salicylic acid). The Y. lipolytica strain expressing a heterologous pathway produced 52.1 ± 1.2 mg/L resveratrol in a small-scale cultivation. The titer increased to 409.0 ± 1.2 mg/L when the strain was further engineered with feedback-insensitive alleles of the key genes in the shikimate pathway and with five additional copies of the heterologous biosynthetic genes. In controlled fed-batch bioreactor, the strain produced 12.4 ± 0.3 g/L resveratrol, the highest reported titer to date for de novo resveratrol production, with a yield on glucose of 54.4 ± 1.6 mg/g and a productivity of 0.14 ± 0.01 g/L/h. The study showed that Y. lipolytica is an attractive host organism for the production of resveratrol and possibly other shikimate-pathway derived metabolites.

SUBMITTER: Saez-Saez J 

PROVIDER: S-EPMC7672257 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Engineering the oleaginous yeast Yarrowia lipolytica for high-level resveratrol production.

Sáez-Sáez Javier J   Wang Guokun G   Marella Eko Roy ER   Sudarsan Suresh S   Cernuda Pastor Marc M   Borodina Irina I  

Metabolic engineering 20200818


Resveratrol is a plant secondary metabolite with multiple health-beneficial properties. Microbial production of resveratrol in model microorganisms requires extensive engineering to reach commercially viable levels. Here, we explored the potential of the non-conventional yeast Yarrowia lipolytica to produce resveratrol and several other shikimate pathway-derived metabolites (p-coumaric acid, cis,cis-muconic acid, and salicylic acid). The Y. lipolytica strain expressing a heterologous pathway pro  ...[more]

Similar Datasets

| S-EPMC6927232 | biostudies-literature
| S-EPMC7418586 | biostudies-literature
| S-EPMC6119263 | biostudies-literature
| S-EPMC5057495 | biostudies-literature
| S-EPMC6781337 | biostudies-literature
2018-12-06 | GSE90993 | GEO
| S-EPMC6346196 | biostudies-literature
2019-04-26 | GSE80717 | GEO